ALPS Advisors’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,032
| Closed | -$218K | – | 992 |
|
|
2024
Q1 | $218K | Buy |
3,032
+130
| +4% | +$9.34K | ﹤0.01% | 960 |
|
|
2023
Q4 | $577K | Sell |
2,902
-269
| -8% | -$53.5K | ﹤0.01% | 584 |
|
|
2023
Q3 | $422K | Buy |
3,171
+15
| +0.5% | +$1.99K | ﹤0.01% | 619 |
|
|
2023
Q2 | $472K | Buy |
3,156
+361
| +13% | +$54K | ﹤0.01% | 623 |
|
|
2023
Q1 | $410K | Sell |
2,795
-81
| -3% | -$11.9K | ﹤0.01% | 611 |
|
|
2022
Q4 | $456K | Buy |
2,876
+853
| +42% | +$135K | ﹤0.01% | 608 |
|
|
2022
Q3 | $389K | Sell |
2,023
-176
| -8% | -$33.8K | ﹤0.01% | 663 |
|
|
2022
Q2 | $321K | Sell |
2,199
-1,600
| -42% | -$234K | ﹤0.01% | 748 |
|
|
2022
Q1 | $668K | Sell |
3,799
-475
| -11% | -$83.5K | 0.01% | 370 |
|
|
2021
Q4 | $1.26M | Sell |
4,274
-243
| -5% | -$71.4K | 0.01% | 331 |
|
|
2021
Q3 | $1.12M | Buy |
4,517
+400
| +10% | +$99.4K | 0.01% | 380 |
|
|
2021
Q2 | $1.05M | Buy |
+4,117
| New | +$1.05M | 0.01% | 399 |
|